MapLight Therapeutics, Inc. (MPLT) stock
MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.57−0.33 (-4.78%)
Close on Nov 17, 2026Market cap $304.70MP/E –Yield –
MapLight Therapeutics cash
Cash and short-term investments held at the end of each period.
MapLight Therapeutics's cash was $304.73M at Jun 30, 2026. For fiscal 2025 it was $453.10M, up 316.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $453.10M | +316.5% |
| FY2024 | Dec 31, 2024 | $108.80M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $304.73M | +180.1% |
| Q1 FY2026 | Mar 31, 2026 | $310.11M | – |
| Q4 FY2025 | Dec 31, 2025 | $453.10M | – |
| Q3 FY2025 | Sep 30, 2025 | $227.20M | – |
| Q4 FY2024 | Dec 31, 2024 | $108.80M | – |
See a number that looks wrong?